Article citationsMore>>

Stelzle, D., Rangaraj, A., Jarvis, J.N., Razakasoa, N.H., Perrin, G., Low-Beer, D., et al. (2025) Prevalence of Advanced HIV Disease in Sub-Saharan Africa: A Multi-Country Analysis of Nationally Representative Household Surveys. The Lancet Global Health, 13, e437-e446.
https://doi.org/10.1016/s2214-109x(24)00538-2

has been cited by the following article:

• TITLE: Immune Reconstitution Inflammatory Syndrome Unmasking Cerebral Toxoplasmosis after Restarting Dolutegravir-Based Antiretroviral Therapy: A Case Report and Mini-Review

  AUTHORS: Martin Herbas Ekat, Tatia Adoua Doukaga, Gilius Axel Aloumba, Médard Amona, Bienvenu Rolland Ossibi Ibara

  KEYWORDS: IRIS, Toxoplasmosis, Dolutegravir

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.15 No.10, September 30, 2026

  ABSTRACT: A 42-year-old woman living with HIV, who had been off antiretroviral therapy for two years, restarted a dolutegravir-based regimen with a baseline plasma viral load of 120,000 copies/mL and a CD4 T-lymphocyte count of 64 cells/mm3. Two months later, despite complete virological suppression and a CD4 count of 201 cells/mm3, she developed headache, seizures, and a motor deficit. Cranial computed tomography (CT) revealed ring-enhancing lesions suggestive of cerebral toxoplasmosis. The timing of events and the rapid virological response led to a diagnosis of immune reconstitution inflammatory syndrome (IRIS) unmasking cerebral toxoplasmosis. The outcome was favourable with co-trimoxazole, corticosteroid therapy, and continuation of antiretroviral therapy. This case highlights the importance of considering IRIS in patients presenting with neurological manifestations after initiation or resumption of effective antiretroviral therapy.